{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:29:00Z","timestamp":1788866940725,"version":"build-2803163510"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"lizhonghu","award":["81902501"],"award-info":[{"award-number":["81902501"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    Septic shock, a life-threatening intensive care unit condition characterized by persistent hypotension and organ dysfunction despite fluid resuscitation, is a leading cause of intensive care unit mortality. Vasoactive drugs are central to hemodynamic support in septic shock but their benefit-potential adverse event trade-off remains controversial; existing studies link high-dose vasopressors to increased mortality, though the association with 28-day mortality is unclear due to limitations like small sample sizes or single-center designs. This retrospective cohort study, based on the Medical Information Mart for Intensive Care-IV database (V3.1), included 2961 adult patients with septic shock who received vasoactive drugs and had hyperlactatemia between 2008 and 2022. The association between total vasoactive drug exposure and mortality was investigated using quartile grouping, Kaplan\u2013Meier (K\u2013M) survival analysis, restricted cubic spline regression, and subgroup analysis. Multivariable Cox proportional hazards models with incremental adjustments for demographics, comorbidities and laboratory markers were applied to evaluate hazard ratios. The overall in-hospital 28-day mortality rate was 31.37%. Mortality significantly increased across quartiles of vasoactive drug exposure, rising from 15.26% to 43.67% (\n                    <jats:italic toggle=\"yes\">\u03c7<\/jats:italic>\n                    \u00b2\u2005=\u2005152.73,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Multivariable Cox models demonstrated consistently elevated mortality risks with higher exposure quartiles, showing significant dose\u2013response trends. Restricted cubic spline analysis showed a nonlinear association between vasoactive drug exposure and 28-day mortality, with a threshold of 470.98 units: below it, lower exposure raised risk; above it, higher exposure reduced risk. Subgroup analyses found this association was more pronounced in males, patients\u2005\u2264\u200560 years old, those without cirrhosis, chronic kidney disease, cancer, and those with comorbid heart failure. The exposure dose of vasoactive drugs in patients with septic shock exhibits a non-linear association with 28-day mortality, with significant heterogeneity in risk characteristics across different dose ranges.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045746","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:00:14Z","timestamp":1763571614000},"page":"e45746","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association between vasoactive drug use and 28-day in-hospital mortality in patients with septic shock in the intensive care unit: A retrospective study based on the MIMIC-IV database"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4162-0529","authenticated-orcid":false,"given":"Qiangqiang","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Medicine, Faculty of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China"},{"name":"General Surgery Department, General Hospital of Central Theater Command,Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Shen","sequence":"additional","affiliation":[{"name":"General Surgery Department, General Hospital of Central Theater Command,Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China"},{"name":"General Surgery Department, General Hospital of Central Theater Command,Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China"},{"name":"General Surgery Department, General Hospital of Central Theater Command,Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Jin","sequence":"additional","affiliation":[{"name":"General Surgery Department, General Hospital of Central Theater Command,Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghu","family":"Li","sequence":"additional","affiliation":[{"name":"General Surgery Department, General Hospital of Central Theater Command,Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.6004\/jnccn.2021.7046","article-title":"Outcomes and predictors of 28-day mortality in patients with hematologic malignancies and septic shock defined by sepsis-3 criteria.","volume":"20","author":"Manjappachar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00101-021-01012-8","article-title":"[SEPSIS-3.0-Is intensive care medicine ready for ICD-11?].","volume":"71","author":"Schmoch","year":"2022","journal-title":"Anaesthesist"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"8703172","DOI":"10.1155\/2018\/8703172","article-title":"Risk factors for sepsis based on sepsis-3 criteria after orthotopic liver transplantation.","volume":"2018","author":"Wang","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12879-022-07543-8","article-title":"Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis.","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016.","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.2024.0179","article-title":"International consensus criteria for pediatric sepsis and septic shock.","volume":"331","author":"Schlapbach","year":"2024","journal-title":"JAMA"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/jcm12093188","article-title":"2023 update on sepsis and septic shock in adult patients: management in the emergency department.","volume":"12","author":"Guarino","year":"2023","journal-title":"J Clin Med"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"1415769","DOI":"10.3389\/fcvm.2024.1415769","article-title":"Prognostic evaluation of the norepinephrine equivalent score and the vasoactive-inotropic score in patients with sepsis and septic shock: a retrospective cohort study.","volume":"11","author":"Li","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7196\/SAMJ.2021.v111i7.14385","article-title":"Early catecholamine dose as a predictor of outcome among patients in a multidisciplinary intensive care unit.","volume":"111","author":"Agael","year":"2021","journal-title":"S Afr Med J"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset.","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41597-023-02136-9","article-title":"Author correction: MIMIC-IV, a freely accessible electronic health record dataset.","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12929-024-01106-6","article-title":"The data artifacts glossary: a community-based repository for bias on health datasets.","volume":"32","author":"Gameiro","year":"2025","journal-title":"J Biomed Sci"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"23769","DOI":"10.1038\/s41598-024-75643-3","article-title":"Association between red blood cells transfusion and 28-day mortality rate in septic patients with concomitant chronic kidney disease.","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-0040-1705181","article-title":"High-dose vasopressor therapy for pediatric septic shock: when is too much?","volume":"9","author":"da Silva","year":"2020","journal-title":"J Pediatr Intensive Care"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy.","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"1126888","DOI":"10.3389\/fcvm.2023.1126888","article-title":"Tendency of dynamic vasoactive and inotropic medications data as a robust predictor of mortality in patients with septic shock: an analysis of the MIMIC-IV database.","volume":"10","author":"Ning","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"1192902","DOI":"10.1155\/2022\/1192902","article-title":"Relationship between dynamic changes of microcirculation flow, tissue perfusion parameters, and lactate level and mortality of septic shock in ICU.","volume":"2022","author":"Yang","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"696138","DOI":"10.3389\/fcvm.2021.696138","article-title":"Inotrope use and intensive care unit mortality in patients with cardiogenic shock: an analysis of a large electronic intensive care unit database.","volume":"8","author":"Gao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R19-20260520","first-page":"EVIDoa2300172","article-title":"High-dose glucocorticoids for the treatment of sudden hearing loss.","volume":"3","author":"Plontke","year":"2024","journal-title":"NEJM Evid"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.3390\/nu15245032","article-title":"High-dose vitamin D supplementation significantly affects the placental transcriptome.","volume":"15","author":"Vestergaard","year":"2023","journal-title":"Nutrients"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"e1908","DOI":"10.1200\/OP.22.00182","article-title":"High-dose methotrexate in patients with lymphoma: predictors of a complicated course.","volume":"18","author":"O\u2019Donoghue","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcrc.2013.09.004","article-title":"Does high-dose vasopressortherapy in medical intensive care patients indicate what we already suspect?","volume":"29","author":"Sviri","year":"2014","journal-title":"J Crit Care"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0310057X0903700212","article-title":"Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study.","volume":"37","author":"Jenkins","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40560-020-00500-0","article-title":"Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.","volume":"8","author":"Zhong","year":"2020","journal-title":"J Intensive Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:00:31Z","timestamp":1779274831000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":24,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045746","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-07-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}